Skip to content
Annika Bansal – Lifestyle
Author:
Ensysce Biosciences
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
April 7, 2026
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
March 19, 2026
Ensysce Biosciences Initiates Live “Ask Me Anything” (AMA) Session Highlighting Growth and Future Plans
March 6, 2026
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
March 5, 2026
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
March 4, 2026
←
Previous Page
1
2